Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3647627016 | Product containing ocrelizumab in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3647628014 | Ocrelizumab in parenteral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3647629018 | Product containing ocrelizumab in parenteral dosage form | en | Synonym (core metadata concept) | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711068012 | Ocrelizumab-containing product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3711069016 | Product containing ocrelizumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ocrelizumab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form (product) | true | Inferred relationship | Some | ||
| Ocrelizumab-containing product in parenteral dose form | Is a | Product containing ocrelizumab (medicinal product) | true | Inferred relationship | Some | ||
| Ocrelizumab-containing product in parenteral dose form | Has active ingredient | Ocrelizumab | true | Inferred relationship | Some | 1 | |
| Ocrelizumab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ocrelizumab only product in parenteral dose form | Is a | True | Ocrelizumab-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR